Human Metabolome Technologies (6090) · InitiativeAdvanced
Joint research with Keio University on metabolome measurement and analysis technologies
First written in FY2017. 2 of 3 entries say "Advanced", first in FY2019. Latest entry: FY2022.
3entries
6years
0from disclosures
How it moved
Same theme, other companies
Joint research with Keio University on metabolome measurement and analysis technologiesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2022AdvancedAnnual report
「The company agreed to arrangements for the 6-year period beginning 1 April 2022 and will pay the Institute for Advanced Biosciences, Keio University, ¥4 million annually as expenses for conducting this joint research.」
The disclosure states that the company agreed to continue joint research with the Institute for Advanced Biosciences, Keio University, for 6 years from 1 April 2022, with annual payments of ¥4 million. - FY2019AdvancedAnnual report
「The company and the Institute for Advanced Biosciences, Keio University, will conduct joint research to improve metabolome measurement and analysis methods and develop new methods.」
The parties agreed to continue the joint research for 3 years from 1 April 2019, with annual payments of ¥4 million. - FY2017First statedAnnual report
「The company and the Institute for Advanced Biosciences, Keio University, will conduct joint research to improve metabolome measurement and analysis methods and develop new methods.」
Under a joint research agreement requiring annual payments of ¥4 million for 3 years from April 2016, the company continues to improve its core technologies and develop new methods.